Introducing our research strategy 2022 - 2028

Better lives today, better lives tomorrow

 

Our research strategy is a roadmap for delivering change in musculoskeletal research. It is the framework we use to guide our research investment for the financial years, 22/23 to 27/28.  

Our research strategy highlights: 

  • Where we will invest directly 
  • Where we won’t invest 
  • Where we will use our voice to influence 

We want research to make arthritis preventable, manageable, and treatable. Research needs to be making a bigger difference to people’s lives, quicker. So, people don’t live with the pain, fatigue and isolation of arthritis.

Our research strategy focuses our research investment to accelerate the pace and precision of musculoskeletal research.

It centres our activity on four areas where we aim to drive positive change for individuals living with arthritis.

Arthritis UK Research Strategy Infographic
  1. Early detection and prevention: Spotting the signs early and reducing the impact of arthritis.

  2. Targeted treatment: More effective drug and non-drug treatments.

  3. Living well: More people living well with their condition, feeling supported in their day-to-day life.

  4. People and partnerships: Making life better for people with arthritis becomes a priority for researchers, funders and investors.

Shaping the future of arthritis research

Our Advisory/Clinical Studies Groups are integral to continuously identifying unmet needs in arthritis research and informing our prioritisation of research areas, they help shape our activities in our priority areas.  Our ‘Gaps and Opportunities for Arthritis Research’ document (Word 199 KB) is dynamically updated with the work of the Groups and other prioritisation settings exercises. 

How we deliver research